Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-12)Premium Content

Sarepta Therapeutics Inc New (SRPT)

2014-10-31@15:30:02 ET
Sarepta Therapeutics to Announce Third Quarter 2014 Financial Results and Corporate Update on November 6, 2014 (BIZ)

2014-10-31@09:21:26 ET
Bank of Japan Hikes Stimulus, Triggers Global Equity Rally (MID)

2014-10-30@01:03:43 ET
Sarepta Therapeutics Offers Update on Eteplirsen (CLM)

2014-10-28@09:22:19 ET
Time Magazine Warns Against Investing In Certain "Ebola Stocks" (BSR)

2014-10-27@16:19:24 ET
Closing Update: Stocks Mixed Ahead of Mid-Week Fed Meeting; S&P Hit By Rout in Energy Sector (MID)

2014-10-27@13:44:21 ET
Sector Update: Health Care Stocks Little Changed; Sarepta Therapeutics Slammed After FDA Asks for More Data on Eteplirsen Drug Candidate (MID)

2014-10-27@13:41:50 ET
Sector Update: Health Care (MID)

2014-10-27@12:40:22 ET
Midday Update: Stocks FluctuatingToday As Pressure on Energy Sector Offset By Technical Support (MID)

2014-10-27@09:23:32 ET
Futures Defensive on German Business Confidence, Brazil's Election, Upcoming Data and FOMC (MID)

2014-10-27@07:06:28 ET
8-K: Sarepta Therapeutics, Inc. (EDK)

2014-10-27@07:00:50 ET
Sarepta Therapeutics Announces Regulatory Update on Eteplirsen (BIZ)

2014-10-21@04:39:00 ET
Research and Markets: Global Potential Analysis of Ebola Drug and Vaccines Market 2014-2020: Leading Companies are Tekmira, BioCryst, Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceutical (BIZ)

2014-10-21@04:14:36 ET
Global Potential Analysis of Ebola Drug and Vaccines Market 2014-2020: Leading Companies are Tekmira, BioCryst, Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceutical (MTO)

2014-10-21@04:09:06 ET
Competitor Analysis: Ebola Virus Vaccines and Therapeutics Report 2014 Featuring Over 30 Insitutions (MTO)

2014-10-21@01:51:01 ET
Sarepta Therapeutics Releases Publication of Ebola and Marburg Phase I Clinical Study Results (CLM)

2014-10-17@13:49:55 ET
Sector Update: Strong Advance for Health Care Sector; Sarepta Therapeutics Up After Positive Results for Possible Ebola Treatment (MID)

2014-10-17@13:47:22 ET
Sector Update: Health Care (MID)

2014-10-08@08:30:36 ET
Sarepta Therapeutics Announces Presentations at the 19th International Congress of the World Muscle Society (BIZ)

2014-10-03@09:31:00 ET
Critical Alerts For MannKind, Sarepta Therapeutics, Noodles & Company, VoxelJet and Lululemon Released By InvestorsObserver (PRN)

2014-10-03@01:10:25 ET
Sarepta Therapeutics Presents Favorable Safety Results from Phase I Clinical Study of Influenza Drug Candidate (CLM)